Choose language
< Return to main menu
e2pcban.jpg weibiaoti-1-652.jpg

Peptide-Drug Conjugate

Services & Solutions

About Us

Services & Solutions

News

Resource

Contact

Career

Peptide Conjugation

Peptide Discovery

Peptide CMC

Peptide Conjugation

Amino Acid

Case Study

PDC

PPMO

PDC

Peptide-drug conjugate is a fast-growing area as a new modality for targeted drug delivery with improved efficacy and reduced side effects for cancer treatment. Our comprehensive peptide platform, coupled with our strong small molecule chemistry capability, provides a one-stop solution for peptide drug conjugate development and manufacturing.

Design linkers with optimal size, suitable release mechanism and compatible conjugation chemistry

Develop payload derivatives with modified toxicity and/or special linkage site

Synthesize customized drug-linker complexes

Seamless scale up from discovery to commercial

Sample payload in stock: MMAE, MMAF, DM1, DM4, PBD, Doxorubicine derivatives etc

Sample linkers in stock: MC-VC-PAB-PNP, Glu-VC-PAB, NHS-Glu-VC-PAB, Azido-Glu-VC-PAB, Hydrazone (acid Sensitive), Disulfide (Glutathione sensitive), SMCC etc

Experience in synthesis of 350+ linkers, 100+ linkers in stock

w_e2_1_03.jpg
w_e2_2_05.jpg
w_e2_3_07.jpg
w_e2_4_09.jpg

Experience in 40+ payload modification, 20+ payloads in stock

w_e2_5_15.jpg
w_e2_6_16.jpg
w_e2_7_17.jpg
w_e2_8_18.jpg


Integrated peptide-toxin development cutting time

E3-Case-study_03.png


Our integrated peptide-toxin development service saved 4-6 months

  • Streamlined process with in parallel activities among 3 different teams on 1 site

  • Swift sample transport and information sharing from upstream to downstream teams

  • Efficient trouble shooting and project collaboration among 3 teams